The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 23, 2025
Filed:
Oct. 22, 2024
Applicant:
Dermira, Inc., Menlo Park, CA (US);
Inventors:
Ferda Cevikbas, Menlo Park, CA (US);
Ashley Jarvis, Menlo Park, CA (US);
Laura Gleave, Menlo Park, CA (US);
Nina Connelly Ursinyova, Menlo Park, CA (US);
Ricky Cain, Menlo Park, CA (US);
Wei Tsung Yau, Menlo Park, CA (US);
Assignee:
Dermira, Inc., Menlo Park, CA (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/427 (2006.01); A61K 31/4184 (2006.01); A61K 31/42 (2006.01); A61K 31/426 (2006.01); A61K 31/428 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
A61K 31/427 (2013.01); A61K 31/4184 (2013.01); A61K 31/42 (2013.01); A61K 31/426 (2013.01); A61K 31/428 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/5377 (2013.01);
Abstract
The present disclosure is directed to use of MrgprX2 antagonists in the treatment of inflammatory disorders, e.g., inflammatory disorders of the skin. This invention is also directed to pharmaceutical compositions comprising a MrgprX2 antagonist and a pharmaceutically or orally acceptable carrier for administration.